COVID-19: Oxford Trial Suspended

The COVID-19 vaccine developed by the University of Oxford has now been halted following discovery of side effects on test subjects. According to Bloomberg, the pause, first reported by Stat on Tuesday, occurred due to a suspected serious adverse reaction in a single person participating in the trial in the UK. The health problems experienced by the individual has not been disclosed, however, the situation will add steam to the concerns of health experts calling for caution in the race for a vaccine for the highly contagious COVID-19. The pause…

Read More

COVID-19: Oxford Vaccine Safe And Triggers Immune Response

A coronavirus vaccine developed by the University of Oxford appears safe and triggers an immune response. Trials involving 1,077 people showed the injection led to them making antibodies and T-cells that can fight coronavirus. The findings are hugely promising, but it is still too soon to know if this is enough to offer protection and larger trials are under way. The UK has already ordered 100 million doses of the vaccine. The vaccine – called ChAdOx1 nCoV-19 – is being developed at unprecedented speed. It is made from a genetically…

Read More

The Oxford Vaccine Passed First Trial Stage

The Oxford vaccine had seemingly passed the first phase of its trial. It emerged that six rhesus macaque monkeys all stayed infection-free four weeks after being exposed to the virus having used the vaccine. This possibly could be the end of the global pandemic and Britain’s nightmare. A pharmaceutical giant agreed to mass-produce the Oxford University’s groundbreaking coronavirus vaccine. Drug conglomerate AstraZeneca signed a non-profit deal to “scale” the revolutionary jab after it sailed through the first round of testing on monkeys and humans. The British Health Secretary Matt Hancock…

Read More

COVID-19 UK: Oxford University To Start Vaccine Trial On Thursday

-YOMMY AYILARA. COVID-19-UK , Oxford University to start vaccine trial on Thursday Imperial College London has asked for people to take part in the study to test if a new potential vaccine is active in tackling COVID-19. The vaccine developed at the University of Oxford will be tested on humans in the UK starting Thursday, the 23rd of April, this week. Those who take part in the Imperial trial could be paid up to £190 to £625 reimbursement for their time. Anyone who is healthy and aged between 18 and…

Read More